In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

La empresa local de secuenciación genética citó ahorros de costos para alinearse con su futura estrategia comercial.

Illumina's financial flexibility declined a bit to purchase Grail, but given the use of equity and limited debt, Illumina's balance sheet remains lightly leveraged. As of December 2024 ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Under CEO Jacob Thaysen, Illumina is working to reignite growth in its core genomics business after spinning off cancer test maker Grail last June, following a long battle with regulators opposed ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...

2024 was a transformative year for GRAIL as we separated from Illumina and began publicly trading in June. In July, we completed final study visits for our two registrational studies, the NHS ...

"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

Illumina respects MOFCOM's decision and will ... the risk of additional litigation arising against us in connection with the GRAIL acquisition; (xiv) our ability to obtain approval by third ...

On 11 February 2025, the Commission unveiled its 2025 work program, titled “Moving forward together: A Bolder, Simpler, Faster Union.” This annual document sets out upcoming legislative and policy ...

Last summer, following a drawn-out divestment from parent company Illumina, Grail announced it would be narrowing its focus only to the Galleri test, pausing its work on other diagnostics to ...

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite filing for an initial public offering (IPO) just a few days ago. Bloomberg says that ...